Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BY 4.0Scientific Reports

Prevalence and risk of colorectal adenomas and colorectal cancer among Thai population aged under 50 years

Abstract

The rising global incidence of early-onset colorectal cancer (CRC) has prompted re-evaluation of screening strategies. This retrospective cross-sectional study aimed to determine the prevalence of colorectal adenoma and CRC and associated clinico-metabolic risk factors among 500 patients younger than 50 years who underwent colonoscopy at Siriraj Hospital between January 2022 and December 2023. The cohort was stratified into three age groups (20–29, 30–39, and 40–49 years), with a secondary analysis comparing the 20–39, 40–44, and 45–49 age subgroups. Multivariable logistic regression analysis was performed to identify independent associated factors for colorectal adenoma and CRC. The prevalence of colorectal adenoma and CRC increased significantly with age: 0% (0/35) in the 20–29 age group, 13.1% (14/107) in the 30–39 age group, and 20.7% (74/358) in the 40–49 age group ( p < 0.001). Secondary analysis revealed a sharp increase in prevalence starting in the early 40s, with 22.7% (30/132) in the 40–44 age group, which was higher than the 9.9% (14/142) observed in the 20–39 age group ( p = 0.004) and similar to the 19.5% (44/226) in the 45–49 age group ( p = 0.463). Multivariable logistic regression model revealed that each 1-year increase in age (aOR 1.06; 95% CI 1.01–1.10; p = 0.018) and male sex (aOR 1.95; 95% CI 1.17–3.25; p = 0.010) were independently associated with a higher prevalence of early-onset colorectal adenoma and CRC. These findings underscore the critical need for prompt diagnostic evaluation and early colonoscopy in adults under 50-particularly males and those in their early 40s-rather than informing average-risk screening guidelines.

Related

  1. Differential risk and protective factors for conventional adenomas and serrated lesions: implications for colorectal cancer prevention
    Junjie Cai, Yiliu Huang, Yi Luo +3
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  2. Correlation between the Prevalence of Colorectal Polyps in Patients with and without a Family History of Colorectal Cancer
    Maura Tarciany Coutinho Cajazeiras de Oliveira, Raissa Scarlet Queiroz Fernandes, Rosilma Gorete Lima Barreto +5
    Journal of ColoproctologyPeer-reviewedCC BYFull textOncologyDOAJ
  3. MLH1 AND MSH2 PROTEIN EXPRESSION LOSS AND MICROSATELLITE INSTABILITY IN COLORECTAL ADENOMAS OF PATIENTS WITH LYNCH SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS Perda de expressão das proteínas MLH1 e MSH2 e instabilidade de microssatélites em adenomas colorretais de pacientes com Síndrome de Lynch: uma Revisão Sistemática e Meta-Análise
    Gustavo Carreira XAVIER, Lucas Araújo VAZ, Marina Cota CALDEIRA +2
    Arquivos de gastroenterologiaPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  4. Association between primary-site surgery and overall survival in non-metastatic and metastatic colorectal cancer: a population-based study using the Surveillance, Epidemiology, and End Results database
    Xueru Fan, Tianzi Luo, Zelun Li +2
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Stage-Stratified Explainable Machine Learning Identifies a Reproducible Transcriptomic Classifier with Stage-Dependent Feature Importance in Colorectal Cancer: A Multi-Cohort Study with Saudi Population Contextualisation
    Asif Hassan Syed, Sultan Alhayyani, Nashwan Alromema +2
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{kotchanan2026prevalence,
  title = {{Prevalence and risk of colorectal adenomas and colorectal cancer among Thai population aged under 50 years}},
  author = {Natrada Kotchanan and Chayanis Kositamongkol and Chonticha Auesomwang},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-73873-1},
  url = {https://www.nature.com/articles/s41598-026-73873-1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Prevalence and risk of colorectal adenomas and colorectal cancer among Thai population aged under 50 years
AU  - Natrada Kotchanan
AU  - Chayanis Kositamongkol
AU  - Chonticha Auesomwang
PY  - 2026
DA  - 2026/10/01
JO  - Scientific Reports
DO  - 10.1038/s41598-026-73873-1
UR  - https://www.nature.com/articles/s41598-026-73873-1
AB  - The rising global incidence of early-onset colorectal cancer (CRC) has prompted re-evaluation of screening strategies. This retrospective cross-sectional study aimed to determine the prevalence of colorectal adenoma and CRC and associated clinico-metabolic risk factors among 500 patients younger than 50 years who underwent colonoscopy at Siriraj Hospital between January 2022 and December 2023. The cohort was stratified into three age groups (20–29, 30–39, and 40–49 years), with a secondary analysis comparing the 20–39, 40–44, and 45–49 age subgroups. Multivariable logistic regression analysis was performed to identify independent associated factors for colorectal adenoma and CRC. The prevalence of colorectal adenoma and CRC increased significantly with age: 0% (0/35) in the 20–29 age group, 13.1% (14/107) in the 30–39 age group, and 20.7% (74/358) in the 40–49 age group ( p < 0.001). Secondary analysis revealed a sharp increase in prevalence starting in the early 40s, with 22.7% (30/132) in the 40–44 age group, which was higher than the 9.9% (14/142) observed in the 20–39 age group ( p = 0.004) and similar to the 19.5% (44/226) in the 45–49 age group ( p = 0.463). Multivariable logistic regression model revealed that each 1-year increase in age (aOR 1.06; 95% CI 1.01–1.10; p = 0.018) and male sex (aOR 1.95; 95% CI 1.17–3.25; p = 0.010) were independently associated with a higher prevalence of early-onset colorectal adenoma and CRC. These findings underscore the critical need for prompt diagnostic evaluation and early colonoscopy in adults under 50-particularly males and those in their early 40s-rather than informing average-risk screening guidelines.
SN  - 2045-2322
ER  -